{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:53:00Z","timestamp":1791910380242,"version":"4.3.4"},"reference-count":71,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.it.2023.02.002","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T08:23:39Z","timestamp":1677659019000},"page":"266-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Multiple sclerosis: role of meningeal lymphoid aggregates in progression independent of relapse activity"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0175-6910","authenticated-orcid":false,"given":"Richard M.","family":"Ransohoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2023.02.002_bb0005","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.it.2023.02.002_bb0010","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature10251","article-title":"Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis","volume":"476","author":"Sawcer","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.it.2023.02.002_bb0015","doi-asserted-by":"crossref","DOI":"10.1126\/science.aav7188","article-title":"Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility","volume":"365","author":"International Multiple Sclerosis Genetics Consortium","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.it.2023.02.002_bb0020","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1093\/brain\/awy287","article-title":"One hundred and fifty years ago Charcot reported multiple sclerosis as a new neurological disease","volume":"141","author":"Zalc","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.it.2023.02.002_bb0025","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/brain\/awh721","article-title":"The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease","volume":"129","author":"Kremenchutzky","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.it.2023.02.002_bb0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jama.2018.20588","article-title":"Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis","volume":"321","author":"Brown","year":"2019","journal-title":"Jama"},{"key":"10.1016\/j.it.2023.02.002_bb0035","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s40263-022-00965-7","article-title":"High-efficacy therapies for treatment-na\u00efve individuals with relapsing-remitting multiple sclerosis","volume":"36","author":"Freeman","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.it.2023.02.002_bb0040","series-title":"McAlpine\u2019s Multiple Sclerosis","first-page":"183","article-title":"The natural history of multiple sclerosis","author":"Confavreux","year":"2006"},{"key":"10.1016\/j.it.2023.02.002_bb0045","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1177\/1352458519866613","article-title":"Age-related decreases in relapses among adults with relapsing-onset multiple sclerosis","volume":"26","author":"Schwehr","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.it.2023.02.002_bb0050","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1212\/WNL.56.3.422","article-title":"Enhancement frequency decreases with increasing age in relapsing-remitting multiple sclerosis","volume":"56","author":"Filippi","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.it.2023.02.002_bb0055","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.arr.2017.10.005","article-title":"The influence and impact of ageing and immunosenescence (ISC) on adaptive immunity during multiple sclerosis (MS) and the animal counterpart experimental autoimmune encephalomyelitis (EAE)","volume":"41","author":"Bolton","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.it.2023.02.002_bb0060","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/1352458512451510","article-title":"Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis","volume":"19","author":"Tutuncu","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.it.2023.02.002_bb0065","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0022-510X(02)00069-2","article-title":"Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease","volume":"206","author":"Bjartmar","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.it.2023.02.002_bb0070","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9440(10)64537-3","article-title":"Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions","volume":"157","author":"Kornek","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.it.2023.02.002_bb0075","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00001756-199501000-00032","article-title":"Traumatic brain injury in rat produces changes of beta-amyloid precursor protein immunoreactivity","volume":"6","author":"Lew\u00e9n","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.it.2023.02.002_bb0080","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/brain\/120.3.393","article-title":"Axonal damage in acute multiple sclerosis lesions","volume":"120","author":"Ferguson","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.it.2023.02.002_bb0085","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1212\/01.wnl.0000284601.54436.e4","article-title":"Cortical demyelination in PML and MS: similarities and differences","volume":"70","author":"Moll","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.it.2023.02.002_bb0090","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/bpa.12813","article-title":"Extensive subpial cortical demyelination is specific to multiple sclerosis","volume":"30","author":"Junker","year":"2020","journal-title":"Brain Pathol."},{"key":"10.1016\/j.it.2023.02.002_bb0095","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1093\/brain\/awr182","article-title":"Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis","volume":"134","author":"Howell","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.it.2023.02.002_bb0100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/brain\/awv337","article-title":"Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant","volume":"139","author":"Steenwijk","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.it.2023.02.002_bb0105","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","article-title":"Multiple sclerosis progression: time for a new mechanism-driven framework","volume":"22","author":"Kuhlmann","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.it.2023.02.002_bb0110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/jamaneurol.2022.4156","article-title":"Time to change the current clinical classification of multiple sclerosis?","volume":"80","author":"Granziera","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.it.2023.02.002_bb0115","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/ana.25463","article-title":"Silent progression in disease activity-free relapsing multiple sclerosis","volume":"85","author":"Cree","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.it.2023.02.002_bb0120","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jamaneurol.2022.1025","article-title":"Association of brain atrophy with disease progression independent of relapse activity in patients with relapsing multiple sclerosis","volume":"79","author":"Cagol","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.it.2023.02.002_bb0125","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1177\/1352458517709619","article-title":"Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study","volume":"24","author":"Kappos","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.it.2023.02.002_bb0130","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/jamaneurol.2020.1568","article-title":"Contribution of relapse-independent progression vs relapse-associated worsening to overall confirmed disability accumulation in typical relapsing multiple sclerosis in a pooled analysis of 2 randomized clinical trials","volume":"77","author":"Kappos","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.it.2023.02.002_bb0135","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jamaneurol.2022.4655","article-title":"Association of early progression independent of relapse activity with long-term disability after a first demyelinating event in multiple sclerosis","volume":"80","author":"Tur","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.it.2023.02.002_bb0140","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2023.02.002_bb0145","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/brain\/awac016","article-title":"How patients with multiple sclerosis acquire disability","volume":"145","author":"Lublin","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.it.2023.02.002_bb0150","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.it.2023.02.002_bb0155","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1177\/13524585221094944","article-title":"Is the effect of drugs in progressive MS only due to an effect on inflammation? A subgroup meta-analysis of randomised trials","volume":"28","author":"Capanna","year":"2022","journal-title":"Mult. Scler."},{"key":"10.1016\/j.it.2023.02.002_bb0160","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(16)31320-4","article-title":"Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function","volume":"389","author":"Ontaneda","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.it.2023.02.002_bb0165","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jns.2006.11.023","article-title":"The place of MRI in monitoring the individual MS patient","volume":"259","author":"Arnold","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.it.2023.02.002_bb0170","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/jamaneurol.2019.2399","article-title":"Association of chronic active multiple sclerosis lesions with disability in vivo","volume":"76","author":"Absinta","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.it.2023.02.002_bb0175","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/14737175.2022.2143265","article-title":"What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?","volume":"22","author":"Martire","year":"2022","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.it.2023.02.002_bb0180","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00401-016-1653-y","article-title":"An updated histological classification system for multiple sclerosis lesions","volume":"133","author":"Kuhlmann","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.it.2023.02.002_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256845","article-title":"The prevalence of paramagnetic rim lesions in multiple sclerosis: A systematic review and meta-analysis","volume":"16","author":"Ng Kee Kwong","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.it.2023.02.002_bb0190","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00401-018-1818-y","article-title":"Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis","volume":"135","author":"Luchetti","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.it.2023.02.002_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2022.103194","article-title":"From pathology to MRI and back: clinically relevant biomarkers of multiple sclerosis lesions","volume":"36","author":"Kolb","year":"2022","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.it.2023.02.002_bb0200","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/ana.25877","article-title":"Paramagnetic rim lesions are specific to multiple sclerosis: an international multicenter 3T MRI study","volume":"88","author":"Maggi","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.it.2023.02.002_bb0205","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1172\/JCI86198","article-title":"Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions","volume":"126","author":"Absinta","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2023.02.002_bb0210","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3389\/fneur.2017.00433","article-title":"The role of T1-weighted derived measures of neurodegeneration for assessing disability progression in multiple sclerosis","volume":"8","author":"Rocca","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.it.2023.02.002_bb0215","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00401-016-1636-z","article-title":"Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging","volume":"133","author":"Dal-Bianco","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.it.2023.02.002_bb0220","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","article-title":"A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis","volume":"597","author":"Absinta","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.it.2023.02.002_bb0225","article-title":"Chronic active multiple sclerosis lesions are poorly responsive to anti-CD20 antibody treatment","author":"Maggi","year":"2022"},{"key":"10.1016\/j.it.2023.02.002_bb0235","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200052","article-title":"Serum GFAP and NfL levels differentiate subsequent progression and disease activity in patients with progressive multiple sclerosis","volume":"10","author":"Barro","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.it.2023.02.002_bb0240","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.3390\/biomedicines10102604","article-title":"A review of compartmentalised inflammation and tertiary lymphoid structures in the pathophysiology of multiple sclerosis","volume":"10","author":"Kee","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.it.2023.02.002_bb0245","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151683","article-title":"Accumulation of meningeal lymphocytes correlates with white matter lesion activity in progressive multiple sclerosis","volume":"7","author":"Ahmed","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.it.2023.02.002_bb0250","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa1100648","article-title":"Inflammatory cortical demyelination in early multiple sclerosis","volume":"365","author":"Lucchinetti","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2023.02.002_bb0255","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.1123","article-title":"Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions","volume":"50","author":"Peterson","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.it.2023.02.002_bb0260","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/brain\/awy006","article-title":"The value of oligoclonal bands in the multiple sclerosis diagnostic criteria","volume":"141","author":"Arrambide","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.it.2023.02.002_bb0265","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1474-4422(05)70071-5","article-title":"Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis","volume":"4","author":"Miller","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.it.2023.02.002_bb0270","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nm1714","article-title":"Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis","volume":"14","author":"Obermeier","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2023.02.002_bb0275","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/brain\/awq350","article-title":"Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis","volume":"134","author":"Lovato","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.it.2023.02.002_bb0280","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.3389\/fimmu.2018.03116","article-title":"Pathogenic mechanisms associated with different clinical courses of multiple sclerosis","volume":"9","author":"Lassmann","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2023.02.002_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.805657","article-title":"How does the immune system enter the brain?","volume":"13","author":"Mapunda","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2023.02.002_bb0290","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ana.410290515","article-title":"Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history","volume":"29","author":"Harris","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.it.2023.02.002_bb0295","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2023.02.002_bb0300","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1007\/s00415-020-09917-x","article-title":"Neurofilaments in progressive multiple sclerosis: a systematic review","volume":"268","author":"Williams","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.it.2023.02.002_bb0305","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1212\/WNL.0000000000012326","article-title":"Chronic white matter inflammation and serum neurofilament levels in multiple sclerosis","volume":"97","author":"Maggi","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.it.2023.02.002_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103927","article-title":"Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapies","volume":"63","author":"Masanneck","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.it.2023.02.002_bb0315","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awm038","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.it.2023.02.002_bb0320","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","article-title":"Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis","volume":"14","author":"Serafini","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.it.2023.02.002_bb0325","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nri3265","article-title":"The anatomical and cellular basis of immune surveillance in the central nervous system","volume":"12","author":"Ransohoff","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2023.02.002_bb0330","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ana.21379","article-title":"Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis","volume":"65","author":"Kivis\u00e4kk","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.it.2023.02.002_bb0335","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1084\/jem.20130699","article-title":"MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies","volume":"210","author":"Molnarfi","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2023.02.002_bb0340","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/cne.21307","article-title":"Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis","volume":"502","author":"Brown","year":"2007","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.it.2023.02.002_bb0345","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0165-5728(99)00082-X","article-title":"Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines","volume":"98","author":"Ransohoff","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.it.2023.02.002_bb0350","doi-asserted-by":"crossref","first-page":"10633","DOI":"10.1523\/JNEUROSCI.22-24-10633.2002","article-title":"Pertussis toxin-induced reversible encephalopathy dependent on monocyte chemoattractant protein-1 overexpression in mice","volume":"22","author":"Huang","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.it.2023.02.002_bb0355","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1096\/fj.04-3104com","article-title":"Chronic expression of monocyte chemoattractant protein-1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice","volume":"19","author":"Huang","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.it.2023.02.002_bb0360","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.193.6.713","article-title":"Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis","volume":"193","author":"Huang","year":"2001","journal-title":"J. Exp. Med."}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490623000273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490623000273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:11:09Z","timestamp":1761462669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471490623000273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1471490623000273"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2023.02.002","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple sclerosis: role of meningeal lymphoid aggregates in progression independent of relapse activity","name":"articletitle","label":"Article Title"},{"value":"Trends in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.it.2023.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}